 |
 |
 |
| Cover | 907 | 841 |
Articles |
|||||
| 841 | PRACTICAL
THERAPEUTICS Osteoarthritis: Diagnosis and Therapeutic Considerations
An estimated 40 million Americans of all ages are affected by osteoarthritis, and 70 to 90 percent of persons older than 75 years have at least one affected joint. New medications can help limit symptoms and improve function. |
||||
| 853 | Recognition and Management of Hereditary Hemochromatosis
The diagnosis of hereditary hemochromatosis, an autosomal recessive single-gene disorder, is based on a combination of clinical, laboratory, and pathologic findings (including elevated serum transferrin saturation) and, possibly, HFE gene testing. Patients with the disorder who have iron overload are usually treated with phlebotomy. |
||||
 |
Patient information: "Hereditary Hemochromatosis," p. 865 | ||||
871 |
COVER
ARTICLE Cholesterol Treatment Guidelines Update
The National Cholesterol Education Program has released its third set of guidelines, reflecting changes in cholesterol management. The new guidelines stress the importance of an aggressive therapeutic approach in the treatment of hypercholesterolemia. |
||||
 |
Editorial: "Improvement in Current Approaches to Lipid Lowering," p. 783 | ||||
| 883 | END-OF-LIFE
CARE Identifying and Managing Preparatory Grief and Depression at the End of Life
The symptoms traditionally used to identify depression may be imprecise in patients who are dying because these symptoms are also present in preparatory grief and as a part of the normal dying process. |
||||
|
Patient information: "Dying and Preparatory Grief," p. 897 | ||||
| 901 | OFFICE
PROCEDURES Lipoma Excision
Lipomas are slow-growing, benign tumors that most often appear in subcutaneous tissues. They can be treated with steroid injections, liposuction, enucleation, or excision. |
||||
|
Patient information: "What Are Lipomas?" p. 905 | ||||
| 907 | Rhabdomyolsis
Rhabdomyolysis can be life-threatening. Early recognition of the syndrome and prompt management of complications are crucial to a successful outcome. |
||||
| 915 | Maternal Serum Triple Analyte Screening in Pregnancy
Serum analyte testing has become an important step in detecting congenital abnormalities. The triple screen, using alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol, provides detection of neural tube defects and increases the detection of trisomies greatly over alpha-fetoprotein alone. |
||||
|
Patient information: "Triple Screening in Pregnancy--What It Is and What to Expect," p. 922 | ||||
Departments |
||
| 761 | Inside AFP | |
| 765 | Change-of-Address Form | |
| 769 | Newsletter | |
| 773 | Quantum Sufficit | |
| 777 | Clinical Quiz | |
| 783 | Editorials
|
|
| 799 | Letters to the
Editor
|
|
| 799 | Correction | |
| 803 | CME Calendar | |
| 833 | Diary from a Week
in Practice |
|
| 925 | BMJ Clinical
Evidence
|
|
| 931 | Tips from Other Journals | |
| 979 | Practice
Guidelines
|
|
| 982 | Clinical Briefs | |
| 989 | Medical Services | |
| 744 | Classified Information | |
Information for
Authors
|
||
Cover illustration © 2002 Floyd E. Hosmer,
Birmingham, Ala.
Copyright © 2002 by the American Academy of Family
Physicians. This content is owned by the AAFP. A person viewing it online may
make one printout of the material and may use that printout only for his or her
personal, non-commercial reference. This material may not otherwise be
downloaded, copied, printed, stored, transmitted or reproduced in any medium,
whether now known or later invented, except as authorized in writing by the
AAFP. Contact afpserv@aafp.org for
copyright questions and/or permission requests.
Search AFP
AFP at a Glance